nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CYP2C9—brain cancer	0.691	1	CbGaD
Capecitabine—CES1—Phase I biotransformations, non P450—PON1—brain cancer	0.00966	0.171	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—RASSF1—brain cancer	0.00522	0.0923	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—DAPK1—brain cancer	0.00336	0.0595	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—HIC1—brain cancer	0.0028	0.0495	CbGpPWpGaD
Capecitabine—TYMP—endothelium—brain cancer	0.00262	0.119	CbGeAlD
Capecitabine—TYMS—Podofilox—Etoposide—brain cancer	0.00245	1	CbGdCrCtD
Capecitabine—TYMP—blood vessel—brain cancer	0.00242	0.11	CbGeAlD
Capecitabine—TYMS—E2F transcription factor network—HIC1—brain cancer	0.00194	0.0343	CbGpPWpGaD
Capecitabine—CES1—Irinotecan Pathway—APC—brain cancer	0.0016	0.0282	CbGpPWpGaD
Capecitabine—TYMS—G1/S-Specific Transcription—CCNE1—brain cancer	0.00132	0.0233	CbGpPWpGaD
Capecitabine—TYMS—One Carbon Metabolism—DNMT1—brain cancer	0.00124	0.0219	CbGpPWpGaD
Capecitabine—CDA—endocrine gland—brain cancer	0.00123	0.0558	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—CDK4—brain cancer	0.00122	0.0215	CbGpPWpGaD
Capecitabine—TYMS—G1/S-Specific Transcription—PCNA—brain cancer	0.00116	0.0206	CbGpPWpGaD
Capecitabine—TYMS—Trans-sulfuration and one carbon metabolism—DNMT1—brain cancer	0.00111	0.0196	CbGpPWpGaD
Capecitabine—TYMS—telencephalon—brain cancer	0.00101	0.0457	CbGeAlD
Capecitabine—TYMP—pituitary gland—brain cancer	0.000955	0.0434	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—CDKN2A—brain cancer	0.00093	0.0165	CbGpPWpGaD
Capecitabine—TYMP—medulla oblongata—brain cancer	0.000921	0.0418	CbGeAlD
Capecitabine—DPYD—brain—brain cancer	0.000913	0.0415	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—ERBB2—brain cancer	0.00089	0.0157	CbGpPWpGaD
Capecitabine—TYMP—midbrain—brain cancer	0.000842	0.0382	CbGeAlD
Capecitabine—TYMS—gonad—brain cancer	0.000839	0.0381	CbGeAlD
Capecitabine—TYMP—spinal cord—brain cancer	0.000821	0.0373	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—CCND1—brain cancer	0.000786	0.0139	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—CCNE1—brain cancer	0.000774	0.0137	CbGpPWpGaD
Capecitabine—TYMP—endocrine gland—brain cancer	0.000739	0.0336	CbGeAlD
Capecitabine—TYMP—head—brain cancer	0.00073	0.0332	CbGeAlD
Capecitabine—TYMS—midbrain—brain cancer	0.000722	0.0328	CbGeAlD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—brain cancer	0.000691	0.0122	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—VEGFA—brain cancer	0.000685	0.0121	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—PCNA—brain cancer	0.000685	0.0121	CbGpPWpGaD
Capecitabine—TYMP—central nervous system—brain cancer	0.000666	0.0303	CbGeAlD
Capecitabine—TYMP—cerebellum—brain cancer	0.000651	0.0296	CbGeAlD
Capecitabine—CES1—endocrine gland—brain cancer	0.000638	0.029	CbGeAlD
Capecitabine—TYMS—endocrine gland—brain cancer	0.000634	0.0288	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—MYC—brain cancer	0.000631	0.0112	CbGpPWpGaD
Capecitabine—CES1—head—brain cancer	0.00063	0.0286	CbGeAlD
Capecitabine—TYMS—head—brain cancer	0.000626	0.0284	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—EGFR—brain cancer	0.000617	0.0109	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—brain cancer	0.000616	0.0109	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—SIRT1—brain cancer	0.000598	0.0106	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CCNE1—brain cancer	0.000591	0.0104	CbGpPWpGaD
Capecitabine—CES1—central nervous system—brain cancer	0.000575	0.0261	CbGeAlD
Capecitabine—TYMS—central nervous system—brain cancer	0.000572	0.026	CbGeAlD
Capecitabine—TYMS—cerebellum—brain cancer	0.000559	0.0254	CbGeAlD
Capecitabine—TYMS—Circadian rythm related genes—NTRK3—brain cancer	0.000556	0.00984	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000531	0.00939	CbGpPWpGaD
Capecitabine—TYMP—brain—brain cancer	0.000529	0.024	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—TP53—brain cancer	0.000518	0.00916	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000499	0.00882	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—brain cancer	0.000493	0.00871	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000473	0.00837	CbGpPWpGaD
Capecitabine—CES1—brain—brain cancer	0.000457	0.0207	CbGeAlD
Capecitabine—TYMS—brain—brain cancer	0.000454	0.0206	CbGeAlD
Capecitabine—TYMS—G1/S Transition—SKP2—brain cancer	0.000443	0.00784	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—SIRT1—brain cancer	0.000415	0.00734	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CCNE1—brain cancer	0.00041	0.00725	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000373	0.0066	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—brain cancer	0.000363	0.00642	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000356	0.0063	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDKN2A—brain cancer	0.000346	0.00612	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000333	0.00589	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000316	0.00558	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000302	0.00533	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000298	0.00528	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—CCNE1—brain cancer	0.000297	0.00526	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000283	0.005	CbGpPWpGaD
Capecitabine—CYP2C9—endocrine gland—brain cancer	0.000277	0.0126	CbGeAlD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000273	0.00482	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PPP1R12A—brain cancer	0.00027	0.00477	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—PCNA—brain cancer	0.000263	0.00466	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP2C9—brain cancer	0.000263	0.00466	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—brain cancer	0.000252	0.00446	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000251	0.00443	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN2A—brain cancer	0.00024	0.00424	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000239	0.00422	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP2C9—brain cancer	0.000235	0.00415	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYC—brain cancer	0.000234	0.00414	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—BSG—brain cancer	0.000224	0.00396	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000222	0.00393	CbGpPWpGaD
Capecitabine—Paraesthesia—Procarbazine—brain cancer	0.000221	0.00097	CcSEcCtD
Capecitabine—Hepatobiliary disease—Temozolomide—brain cancer	0.000221	0.000969	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000218	0.000958	CcSEcCtD
Capecitabine—Haemoglobin—Carmustine—brain cancer	0.000218	0.000957	CcSEcCtD
Capecitabine—Haemorrhage—Carmustine—brain cancer	0.000217	0.000952	CcSEcCtD
Capecitabine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000217	0.000951	CcSEcCtD
Capecitabine—Anaemia—Hydroxyurea—brain cancer	0.000216	0.000947	CcSEcCtD
Capecitabine—Hypoaesthesia—Carmustine—brain cancer	0.000216	0.000947	CcSEcCtD
Capecitabine—Decreased appetite—Procarbazine—brain cancer	0.000214	0.00094	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000214	0.000938	CcSEcCtD
Capecitabine—Oedema peripheral—Carmustine—brain cancer	0.000214	0.000938	CcSEcCtD
Capecitabine—Connective tissue disorder—Carmustine—brain cancer	0.000213	0.000935	CcSEcCtD
Capecitabine—Fatigue—Procarbazine—brain cancer	0.000212	0.000932	CcSEcCtD
Capecitabine—Haemoglobin—Temozolomide—brain cancer	0.000211	0.000924	CcSEcCtD
Capecitabine—Malaise—Hydroxyurea—brain cancer	0.000211	0.000924	CcSEcCtD
Capecitabine—Constipation—Procarbazine—brain cancer	0.000211	0.000924	CcSEcCtD
Capecitabine—Pain—Procarbazine—brain cancer	0.000211	0.000924	CcSEcCtD
Capecitabine—Hepatitis—Temozolomide—brain cancer	0.00021	0.00092	CcSEcCtD
Capecitabine—Haemorrhage—Temozolomide—brain cancer	0.00021	0.00092	CcSEcCtD
Capecitabine—Dysphagia—Etoposide—brain cancer	0.00021	0.000919	CcSEcCtD
Capecitabine—Leukopenia—Hydroxyurea—brain cancer	0.000209	0.000917	CcSEcCtD
Capecitabine—Visual impairment—Carmustine—brain cancer	0.000209	0.000917	CcSEcCtD
Capecitabine—Hypoaesthesia—Temozolomide—brain cancer	0.000209	0.000915	CcSEcCtD
Capecitabine—Pharyngitis—Temozolomide—brain cancer	0.000208	0.000913	CcSEcCtD
Capecitabine—Urinary tract disorder—Temozolomide—brain cancer	0.000207	0.000908	CcSEcCtD
Capecitabine—Oedema peripheral—Temozolomide—brain cancer	0.000206	0.000906	CcSEcCtD
Capecitabine—Bronchospasm—Etoposide—brain cancer	0.000206	0.000904	CcSEcCtD
Capecitabine—Connective tissue disorder—Temozolomide—brain cancer	0.000206	0.000904	CcSEcCtD
Capecitabine—Urethral disorder—Temozolomide—brain cancer	0.000205	0.000902	CcSEcCtD
Capecitabine—Sweating increased—Etoposide—brain cancer	0.000204	0.000896	CcSEcCtD
Capecitabine—Feeling abnormal—Procarbazine—brain cancer	0.000203	0.000891	CcSEcCtD
Capecitabine—Eye disorder—Carmustine—brain cancer	0.000203	0.000889	CcSEcCtD
Capecitabine—Visual impairment—Temozolomide—brain cancer	0.000202	0.000886	CcSEcCtD
Capecitabine—Gastrointestinal pain—Procarbazine—brain cancer	0.000201	0.000884	CcSEcCtD
Capecitabine—Flushing—Carmustine—brain cancer	0.000201	0.000883	CcSEcCtD
Capecitabine—CDA—Metabolism—BSG—brain cancer	0.0002	0.00353	CbGpPWpGaD
Capecitabine—Pancytopenia—Etoposide—brain cancer	0.000199	0.000873	CcSEcCtD
Capecitabine—Erythema multiforme—Temozolomide—brain cancer	0.000198	0.00087	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000197	0.000867	CcSEcCtD
Capecitabine—Discomfort—Hydroxyurea—brain cancer	0.000196	0.000862	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000196	0.00347	CbGpPWpGaD
Capecitabine—Neutropenia—Etoposide—brain cancer	0.000196	0.00086	CcSEcCtD
Capecitabine—Eye disorder—Temozolomide—brain cancer	0.000196	0.00086	CcSEcCtD
Capecitabine—Urticaria—Procarbazine—brain cancer	0.000196	0.000859	CcSEcCtD
Capecitabine—Tinnitus—Temozolomide—brain cancer	0.000195	0.000858	CcSEcCtD
Capecitabine—Abdominal pain—Procarbazine—brain cancer	0.000195	0.000854	CcSEcCtD
Capecitabine—Body temperature increased—Procarbazine—brain cancer	0.000195	0.000854	CcSEcCtD
Capecitabine—Cardiac disorder—Temozolomide—brain cancer	0.000195	0.000854	CcSEcCtD
Capecitabine—Flushing—Temozolomide—brain cancer	0.000195	0.000854	CcSEcCtD
Capecitabine—Arrhythmia—Carmustine—brain cancer	0.000194	0.00085	CcSEcCtD
Capecitabine—DPYD—Metabolism—IDH1—brain cancer	0.000193	0.00341	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000192	0.0034	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000192	0.00339	CbGpPWpGaD
Capecitabine—Alopecia—Carmustine—brain cancer	0.000192	0.000841	CcSEcCtD
Capecitabine—Oedema—Hydroxyurea—brain cancer	0.000191	0.000836	CcSEcCtD
Capecitabine—Angiopathy—Temozolomide—brain cancer	0.00019	0.000834	CcSEcCtD
Capecitabine—Mental disorder—Carmustine—brain cancer	0.00019	0.000834	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00019	0.00336	CbGpPWpGaD
Capecitabine—Infection—Hydroxyurea—brain cancer	0.000189	0.000831	CcSEcCtD
Capecitabine—Immune system disorder—Temozolomide—brain cancer	0.000189	0.000831	CcSEcCtD
Capecitabine—Mediastinal disorder—Temozolomide—brain cancer	0.000189	0.000829	CcSEcCtD
Capecitabine—Malnutrition—Carmustine—brain cancer	0.000189	0.000829	CcSEcCtD
Capecitabine—Erythema—Carmustine—brain cancer	0.000189	0.000829	CcSEcCtD
Capecitabine—Chills—Temozolomide—brain cancer	0.000188	0.000825	CcSEcCtD
Capecitabine—Pneumonia—Etoposide—brain cancer	0.000188	0.000825	CcSEcCtD
Capecitabine—TYMP—Metabolism—CYP2C9—brain cancer	0.000188	0.00332	CbGpPWpGaD
Capecitabine—Nervous system disorder—Hydroxyurea—brain cancer	0.000187	0.00082	CcSEcCtD
Capecitabine—Infestation—Etoposide—brain cancer	0.000187	0.00082	CcSEcCtD
Capecitabine—Infestation NOS—Etoposide—brain cancer	0.000187	0.00082	CcSEcCtD
Capecitabine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000187	0.000819	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000185	0.000813	CcSEcCtD
Capecitabine—Alopecia—Temozolomide—brain cancer	0.000185	0.000813	CcSEcCtD
Capecitabine—Skin disorder—Hydroxyurea—brain cancer	0.000185	0.000812	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—SIRT1—brain cancer	0.000185	0.00326	CbGpPWpGaD
Capecitabine—Acute coronary syndrome—Etoposide—brain cancer	0.000184	0.000808	CcSEcCtD
Capecitabine—Renal failure—Etoposide—brain cancer	0.000184	0.000806	CcSEcCtD
Capecitabine—Mental disorder—Temozolomide—brain cancer	0.000184	0.000806	CcSEcCtD
Capecitabine—Neuropathy peripheral—Etoposide—brain cancer	0.000183	0.000804	CcSEcCtD
Capecitabine—Myocardial infarction—Etoposide—brain cancer	0.000183	0.000804	CcSEcCtD
Capecitabine—Back pain—Carmustine—brain cancer	0.000183	0.000801	CcSEcCtD
Capecitabine—Erythema—Temozolomide—brain cancer	0.000182	0.000801	CcSEcCtD
Capecitabine—Malnutrition—Temozolomide—brain cancer	0.000182	0.000801	CcSEcCtD
Capecitabine—Jaundice—Etoposide—brain cancer	0.000182	0.000799	CcSEcCtD
Capecitabine—Stomatitis—Etoposide—brain cancer	0.000182	0.000799	CcSEcCtD
Capecitabine—Anorexia—Hydroxyurea—brain cancer	0.000182	0.000797	CcSEcCtD
Capecitabine—Hypersensitivity—Procarbazine—brain cancer	0.000181	0.000796	CcSEcCtD
Capecitabine—Dysgeusia—Temozolomide—brain cancer	0.000179	0.000784	CcSEcCtD
Capecitabine—Vision blurred—Carmustine—brain cancer	0.000178	0.000781	CcSEcCtD
Capecitabine—Tremor—Carmustine—brain cancer	0.000177	0.000776	CcSEcCtD
Capecitabine—Asthenia—Procarbazine—brain cancer	0.000177	0.000775	CcSEcCtD
Capecitabine—Hepatobiliary disease—Etoposide—brain cancer	0.000177	0.000775	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000177	0.00312	CbGpPWpGaD
Capecitabine—Back pain—Temozolomide—brain cancer	0.000176	0.000774	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000176	0.00312	CbGpPWpGaD
Capecitabine—Anaemia—Carmustine—brain cancer	0.000174	0.000766	CcSEcCtD
Capecitabine—Agranulocytosis—Etoposide—brain cancer	0.000174	0.000765	CcSEcCtD
Capecitabine—Pruritus—Procarbazine—brain cancer	0.000174	0.000765	CcSEcCtD
Capecitabine—Vision blurred—Temozolomide—brain cancer	0.000172	0.000755	CcSEcCtD
Capecitabine—CDA—Metabolism—IDH1—brain cancer	0.000172	0.00304	CbGpPWpGaD
Capecitabine—Tremor—Temozolomide—brain cancer	0.000171	0.00075	CcSEcCtD
Capecitabine—Dyspnoea—Hydroxyurea—brain cancer	0.00017	0.000746	CcSEcCtD
Capecitabine—Ill-defined disorder—Temozolomide—brain cancer	0.000169	0.000743	CcSEcCtD
Capecitabine—Leukopenia—Carmustine—brain cancer	0.000169	0.000742	CcSEcCtD
Capecitabine—Anaemia—Temozolomide—brain cancer	0.000169	0.00074	CcSEcCtD
Capecitabine—Diarrhoea—Procarbazine—brain cancer	0.000168	0.000739	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000168	0.00298	CbGpPWpGaD
Capecitabine—Dyspepsia—Hydroxyurea—brain cancer	0.000168	0.000736	CcSEcCtD
Capecitabine—Hypoaesthesia—Etoposide—brain cancer	0.000167	0.000732	CcSEcCtD
Capecitabine—Decreased appetite—Hydroxyurea—brain cancer	0.000166	0.000727	CcSEcCtD
Capecitabine—Urinary tract disorder—Etoposide—brain cancer	0.000166	0.000727	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000165	0.000722	CcSEcCtD
Capecitabine—Malaise—Temozolomide—brain cancer	0.000165	0.000722	CcSEcCtD
Capecitabine—Urethral disorder—Etoposide—brain cancer	0.000164	0.000721	CcSEcCtD
Capecitabine—Fatigue—Hydroxyurea—brain cancer	0.000164	0.000721	CcSEcCtD
Capecitabine—Vertigo—Temozolomide—brain cancer	0.000164	0.000719	CcSEcCtD
Capecitabine—Leukopenia—Temozolomide—brain cancer	0.000163	0.000717	CcSEcCtD
Capecitabine—Hypertension—Carmustine—brain cancer	0.000163	0.000715	CcSEcCtD
Capecitabine—Pain—Hydroxyurea—brain cancer	0.000163	0.000715	CcSEcCtD
Capecitabine—Constipation—Hydroxyurea—brain cancer	0.000163	0.000715	CcSEcCtD
Capecitabine—Dizziness—Procarbazine—brain cancer	0.000163	0.000715	CcSEcCtD
Capecitabine—TYMS—E2F transcription factor network—MYC—brain cancer	0.000163	0.00288	CbGpPWpGaD
Capecitabine—Palpitations—Temozolomide—brain cancer	0.000161	0.000708	CcSEcCtD
Capecitabine—Myalgia—Carmustine—brain cancer	0.000161	0.000705	CcSEcCtD
Capecitabine—Chest pain—Carmustine—brain cancer	0.000161	0.000705	CcSEcCtD
Capecitabine—Anxiety—Carmustine—brain cancer	0.00016	0.000703	CcSEcCtD
Capecitabine—TYMP—Metabolism—BSG—brain cancer	0.00016	0.00282	CbGpPWpGaD
Capecitabine—Cough—Temozolomide—brain cancer	0.000159	0.000699	CcSEcCtD
Capecitabine—Erythema multiforme—Etoposide—brain cancer	0.000159	0.000696	CcSEcCtD
Capecitabine—Hypertension—Temozolomide—brain cancer	0.000158	0.000691	CcSEcCtD
Capecitabine—Feeling abnormal—Hydroxyurea—brain cancer	0.000157	0.000689	CcSEcCtD
Capecitabine—Eye disorder—Etoposide—brain cancer	0.000157	0.000688	CcSEcCtD
Capecitabine—Vomiting—Procarbazine—brain cancer	0.000157	0.000687	CcSEcCtD
Capecitabine—Cardiac disorder—Etoposide—brain cancer	0.000156	0.000683	CcSEcCtD
Capecitabine—Flushing—Etoposide—brain cancer	0.000156	0.000683	CcSEcCtD
Capecitabine—Confusional state—Carmustine—brain cancer	0.000155	0.000682	CcSEcCtD
Capecitabine—Arthralgia—Temozolomide—brain cancer	0.000155	0.000682	CcSEcCtD
Capecitabine—Myalgia—Temozolomide—brain cancer	0.000155	0.000682	CcSEcCtD
Capecitabine—Rash—Procarbazine—brain cancer	0.000155	0.000681	CcSEcCtD
Capecitabine—Dermatitis—Procarbazine—brain cancer	0.000155	0.000681	CcSEcCtD
Capecitabine—Anxiety—Temozolomide—brain cancer	0.000155	0.000679	CcSEcCtD
Capecitabine—Headache—Procarbazine—brain cancer	0.000154	0.000677	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000154	0.000677	CcSEcCtD
Capecitabine—Oedema—Carmustine—brain cancer	0.000154	0.000676	CcSEcCtD
Capecitabine—Discomfort—Temozolomide—brain cancer	0.000153	0.000673	CcSEcCtD
Capecitabine—Infection—Carmustine—brain cancer	0.000153	0.000672	CcSEcCtD
Capecitabine—DPYD—Metabolism—ENO2—brain cancer	0.000152	0.00269	CbGpPWpGaD
Capecitabine—Angiopathy—Etoposide—brain cancer	0.000152	0.000668	CcSEcCtD
Capecitabine—Dry mouth—Temozolomide—brain cancer	0.000152	0.000667	CcSEcCtD
Capecitabine—Immune system disorder—Etoposide—brain cancer	0.000151	0.000665	CcSEcCtD
Capecitabine—Mediastinal disorder—Etoposide—brain cancer	0.000151	0.000663	CcSEcCtD
Capecitabine—Thrombocytopenia—Carmustine—brain cancer	0.000151	0.000662	CcSEcCtD
Capecitabine—Body temperature increased—Hydroxyurea—brain cancer	0.000151	0.000661	CcSEcCtD
Capecitabine—Chills—Etoposide—brain cancer	0.00015	0.00066	CcSEcCtD
Capecitabine—Tachycardia—Carmustine—brain cancer	0.00015	0.00066	CcSEcCtD
Capecitabine—Confusional state—Temozolomide—brain cancer	0.00015	0.000659	CcSEcCtD
Capecitabine—Oedema—Temozolomide—brain cancer	0.000149	0.000653	CcSEcCtD
Capecitabine—Alopecia—Etoposide—brain cancer	0.000148	0.00065	CcSEcCtD
Capecitabine—Infection—Temozolomide—brain cancer	0.000148	0.000649	CcSEcCtD
Capecitabine—Anorexia—Carmustine—brain cancer	0.000147	0.000645	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000147	0.00259	CbGpPWpGaD
Capecitabine—Nausea—Procarbazine—brain cancer	0.000146	0.000642	CcSEcCtD
Capecitabine—Nervous system disorder—Temozolomide—brain cancer	0.000146	0.000641	CcSEcCtD
Capecitabine—Thrombocytopenia—Temozolomide—brain cancer	0.000146	0.00064	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000145	0.00257	CbGpPWpGaD
Capecitabine—Skin disorder—Temozolomide—brain cancer	0.000145	0.000635	CcSEcCtD
Capecitabine—Hypotension—Carmustine—brain cancer	0.000144	0.000632	CcSEcCtD
Capecitabine—Hyperhidrosis—Temozolomide—brain cancer	0.000144	0.000632	CcSEcCtD
Capecitabine—Dysgeusia—Etoposide—brain cancer	0.000143	0.000627	CcSEcCtD
Capecitabine—Anorexia—Temozolomide—brain cancer	0.000142	0.000623	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000141	0.0025	CbGpPWpGaD
Capecitabine—Back pain—Etoposide—brain cancer	0.000141	0.00062	CcSEcCtD
Capecitabine—Hypersensitivity—Hydroxyurea—brain cancer	0.00014	0.000616	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00014	0.000616	CcSEcCtD
Capecitabine—Muscle spasms—Etoposide—brain cancer	0.00014	0.000616	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—CDK4—brain cancer	0.00014	0.00247	CbGpPWpGaD
Capecitabine—Insomnia—Carmustine—brain cancer	0.000139	0.000612	CcSEcCtD
Capecitabine—Paraesthesia—Carmustine—brain cancer	0.000138	0.000607	CcSEcCtD
Capecitabine—Dyspnoea—Carmustine—brain cancer	0.000137	0.000603	CcSEcCtD
Capecitabine—TYMP—Metabolism—IDH1—brain cancer	0.000137	0.00243	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—SKP2—brain cancer	0.000137	0.00242	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000137	0.00242	CbGpPWpGaD
Capecitabine—Asthenia—Hydroxyurea—brain cancer	0.000137	0.0006	CcSEcCtD
Capecitabine—CDA—Metabolism—ENO2—brain cancer	0.000136	0.0024	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000136	0.000595	CcSEcCtD
Capecitabine—Ill-defined disorder—Etoposide—brain cancer	0.000135	0.000594	CcSEcCtD
Capecitabine—Anaemia—Etoposide—brain cancer	0.000135	0.000592	CcSEcCtD
Capecitabine—Insomnia—Temozolomide—brain cancer	0.000135	0.000591	CcSEcCtD
Capecitabine—Decreased appetite—Carmustine—brain cancer	0.000134	0.000588	CcSEcCtD
Capecitabine—Paraesthesia—Temozolomide—brain cancer	0.000134	0.000587	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Carmustine—brain cancer	0.000133	0.000584	CcSEcCtD
Capecitabine—Dyspnoea—Temozolomide—brain cancer	0.000133	0.000583	CcSEcCtD
Capecitabine—Constipation—Carmustine—brain cancer	0.000132	0.000578	CcSEcCtD
Capecitabine—Pain—Carmustine—brain cancer	0.000132	0.000578	CcSEcCtD
Capecitabine—Malaise—Etoposide—brain cancer	0.000132	0.000578	CcSEcCtD
Capecitabine—Vertigo—Etoposide—brain cancer	0.000131	0.000576	CcSEcCtD
Capecitabine—Dyspepsia—Temozolomide—brain cancer	0.000131	0.000575	CcSEcCtD
Capecitabine—Leukopenia—Etoposide—brain cancer	0.000131	0.000573	CcSEcCtD
Capecitabine—Diarrhoea—Hydroxyurea—brain cancer	0.00013	0.000572	CcSEcCtD
Capecitabine—Decreased appetite—Temozolomide—brain cancer	0.000129	0.000568	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000129	0.000564	CcSEcCtD
Capecitabine—Fatigue—Temozolomide—brain cancer	0.000128	0.000563	CcSEcCtD
Capecitabine—Loss of consciousness—Etoposide—brain cancer	0.000128	0.000563	CcSEcCtD
Capecitabine—Cough—Etoposide—brain cancer	0.000127	0.000559	CcSEcCtD
Capecitabine—Pain—Temozolomide—brain cancer	0.000127	0.000559	CcSEcCtD
Capecitabine—Constipation—Temozolomide—brain cancer	0.000127	0.000559	CcSEcCtD
Capecitabine—Feeling abnormal—Carmustine—brain cancer	0.000127	0.000557	CcSEcCtD
Capecitabine—Hypertension—Etoposide—brain cancer	0.000126	0.000553	CcSEcCtD
Capecitabine—Dizziness—Hydroxyurea—brain cancer	0.000126	0.000553	CcSEcCtD
Capecitabine—Gastrointestinal pain—Carmustine—brain cancer	0.000126	0.000553	CcSEcCtD
Capecitabine—Chest pain—Etoposide—brain cancer	0.000124	0.000545	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000124	0.00219	CbGpPWpGaD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000123	0.000542	CcSEcCtD
Capecitabine—Discomfort—Etoposide—brain cancer	0.000123	0.000539	CcSEcCtD
Capecitabine—Feeling abnormal—Temozolomide—brain cancer	0.000123	0.000538	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—SKP2—brain cancer	0.000122	0.00217	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK6—brain cancer	0.000122	0.00216	CbGpPWpGaD
Capecitabine—Abdominal pain—Carmustine—brain cancer	0.000122	0.000535	CcSEcCtD
Capecitabine—Body temperature increased—Carmustine—brain cancer	0.000122	0.000535	CcSEcCtD
Capecitabine—Gastrointestinal pain—Temozolomide—brain cancer	0.000122	0.000534	CcSEcCtD
Capecitabine—Vomiting—Hydroxyurea—brain cancer	0.000121	0.000532	CcSEcCtD
Capecitabine—Rash—Hydroxyurea—brain cancer	0.00012	0.000527	CcSEcCtD
Capecitabine—Confusional state—Etoposide—brain cancer	0.00012	0.000527	CcSEcCtD
Capecitabine—Dermatitis—Hydroxyurea—brain cancer	0.00012	0.000527	CcSEcCtD
Capecitabine—Headache—Hydroxyurea—brain cancer	0.000119	0.000524	CcSEcCtD
Capecitabine—Infection—Etoposide—brain cancer	0.000118	0.000519	CcSEcCtD
Capecitabine—Urticaria—Temozolomide—brain cancer	0.000118	0.000519	CcSEcCtD
Capecitabine—TYMS—G1/S Transition—MYC—brain cancer	0.000118	0.00209	CbGpPWpGaD
Capecitabine—Abdominal pain—Temozolomide—brain cancer	0.000118	0.000517	CcSEcCtD
Capecitabine—Body temperature increased—Temozolomide—brain cancer	0.000118	0.000517	CcSEcCtD
Capecitabine—Thrombocytopenia—Etoposide—brain cancer	0.000117	0.000512	CcSEcCtD
Capecitabine—Tachycardia—Etoposide—brain cancer	0.000116	0.00051	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000116	0.00205	CbGpPWpGaD
Capecitabine—Skin disorder—Etoposide—brain cancer	0.000116	0.000508	CcSEcCtD
Capecitabine—Hyperhidrosis—Etoposide—brain cancer	0.000115	0.000505	CcSEcCtD
Capecitabine—Anorexia—Etoposide—brain cancer	0.000114	0.000498	CcSEcCtD
Capecitabine—Hypersensitivity—Carmustine—brain cancer	0.000114	0.000498	CcSEcCtD
Capecitabine—Nausea—Hydroxyurea—brain cancer	0.000113	0.000497	CcSEcCtD
Capecitabine—Hypotension—Etoposide—brain cancer	0.000111	0.000489	CcSEcCtD
Capecitabine—Asthenia—Carmustine—brain cancer	0.000111	0.000485	CcSEcCtD
Capecitabine—Hypersensitivity—Temozolomide—brain cancer	0.00011	0.000481	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDK6—brain cancer	0.000109	0.00193	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ENO2—brain cancer	0.000108	0.00192	CbGpPWpGaD
Capecitabine—Paraesthesia—Etoposide—brain cancer	0.000107	0.00047	CcSEcCtD
Capecitabine—Asthenia—Temozolomide—brain cancer	0.000107	0.000469	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000106	0.00188	CbGpPWpGaD
Capecitabine—Dyspnoea—Etoposide—brain cancer	0.000106	0.000466	CcSEcCtD
Capecitabine—Diarrhoea—Carmustine—brain cancer	0.000105	0.000463	CcSEcCtD
Capecitabine—Pruritus—Temozolomide—brain cancer	0.000105	0.000462	CcSEcCtD
Capecitabine—Decreased appetite—Etoposide—brain cancer	0.000104	0.000455	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Etoposide—brain cancer	0.000103	0.000451	CcSEcCtD
Capecitabine—Fatigue—Etoposide—brain cancer	0.000103	0.000451	CcSEcCtD
Capecitabine—Dizziness—Carmustine—brain cancer	0.000102	0.000447	CcSEcCtD
Capecitabine—Pain—Etoposide—brain cancer	0.000102	0.000447	CcSEcCtD
Capecitabine—Constipation—Etoposide—brain cancer	0.000102	0.000447	CcSEcCtD
Capecitabine—Diarrhoea—Temozolomide—brain cancer	0.000102	0.000447	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—brain cancer	9.94e-05	0.00176	CbGpPWpGaD
Capecitabine—Dizziness—Temozolomide—brain cancer	9.85e-05	0.000432	CcSEcCtD
Capecitabine—Feeling abnormal—Etoposide—brain cancer	9.82e-05	0.000431	CcSEcCtD
Capecitabine—Vomiting—Carmustine—brain cancer	9.8e-05	0.00043	CcSEcCtD
Capecitabine—Gastrointestinal pain—Etoposide—brain cancer	9.74e-05	0.000428	CcSEcCtD
Capecitabine—Rash—Carmustine—brain cancer	9.71e-05	0.000426	CcSEcCtD
Capecitabine—Dermatitis—Carmustine—brain cancer	9.71e-05	0.000426	CcSEcCtD
Capecitabine—Headache—Carmustine—brain cancer	9.65e-05	0.000424	CcSEcCtD
Capecitabine—TYMS—Metabolism—CYP2C9—brain cancer	9.6e-05	0.0017	CbGpPWpGaD
Capecitabine—Vomiting—Temozolomide—brain cancer	9.47e-05	0.000415	CcSEcCtD
Capecitabine—Urticaria—Etoposide—brain cancer	9.47e-05	0.000415	CcSEcCtD
Capecitabine—Abdominal pain—Etoposide—brain cancer	9.42e-05	0.000413	CcSEcCtD
Capecitabine—Body temperature increased—Etoposide—brain cancer	9.42e-05	0.000413	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.39e-05	0.00166	CbGpPWpGaD
Capecitabine—Rash—Temozolomide—brain cancer	9.39e-05	0.000412	CcSEcCtD
Capecitabine—Dermatitis—Temozolomide—brain cancer	9.38e-05	0.000412	CcSEcCtD
Capecitabine—Headache—Temozolomide—brain cancer	9.33e-05	0.000409	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.3e-05	0.00164	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCNE1—brain cancer	9.19e-05	0.00163	CbGpPWpGaD
Capecitabine—Nausea—Carmustine—brain cancer	9.15e-05	0.000402	CcSEcCtD
Capecitabine—Nausea—Temozolomide—brain cancer	8.84e-05	0.000388	CcSEcCtD
Capecitabine—Hypersensitivity—Etoposide—brain cancer	8.78e-05	0.000385	CcSEcCtD
Capecitabine—Asthenia—Etoposide—brain cancer	8.55e-05	0.000375	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—BRCA2—brain cancer	8.49e-05	0.0015	CbGpPWpGaD
Capecitabine—Pruritus—Etoposide—brain cancer	8.43e-05	0.00037	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CCNE1—brain cancer	8.22e-05	0.00145	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.19e-05	0.00145	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—BSG—brain cancer	8.16e-05	0.00144	CbGpPWpGaD
Capecitabine—Diarrhoea—Etoposide—brain cancer	8.15e-05	0.000358	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—PCNA—brain cancer	8.14e-05	0.00144	CbGpPWpGaD
Capecitabine—Dizziness—Etoposide—brain cancer	7.88e-05	0.000346	CcSEcCtD
Capecitabine—Vomiting—Etoposide—brain cancer	7.58e-05	0.000332	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.53e-05	0.00133	CbGpPWpGaD
Capecitabine—Rash—Etoposide—brain cancer	7.51e-05	0.00033	CcSEcCtD
Capecitabine—Dermatitis—Etoposide—brain cancer	7.51e-05	0.000329	CcSEcCtD
Capecitabine—Headache—Etoposide—brain cancer	7.46e-05	0.000328	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.37e-05	0.0013	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—PCNA—brain cancer	7.28e-05	0.00129	CbGpPWpGaD
Capecitabine—Nausea—Etoposide—brain cancer	7.08e-05	0.000311	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDK4—brain cancer	7.04e-05	0.00125	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—IDH1—brain cancer	7.02e-05	0.00124	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CG—brain cancer	6.98e-05	0.00124	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDK4—brain cancer	6.29e-05	0.00111	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CG—brain cancer	6.22e-05	0.0011	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.19e-05	0.00109	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—brain cancer	5.94e-05	0.00105	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ENO2—brain cancer	5.55e-05	0.000981	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—brain cancer	5.38e-05	0.000952	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CG—brain cancer	4.98e-05	0.00088	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2A—brain cancer	4.81e-05	0.000851	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—brain cancer	4.55e-05	0.000804	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.54e-05	0.000804	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND1—brain cancer	4.06e-05	0.000719	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—brain cancer	3.65e-05	0.000645	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—brain cancer	3.26e-05	0.000577	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—brain cancer	2.68e-05	0.000474	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CG—brain cancer	2.55e-05	0.00045	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BSG—brain cancer	2.35e-05	0.000416	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—IDH1—brain cancer	2.02e-05	0.000358	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.65e-05	0.000291	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ENO2—brain cancer	1.6e-05	0.000283	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—brain cancer	7.34e-06	0.00013	CbGpPWpGaD
